Research and Markets (http://www.researchandmarkets.com/research/f10fda/commercial_insight) has announced the addition of the "Commercial Insight: Hormonal Contraceptives - Look Beyond Oral Contraception for a Competitive Edge" report to their offering.
Since the 1960s, hormonal contraceptives have been widely used as effective birth control in the developed world. Although they are mainly used to prevent pregnancies, they can be used for treating other conditions such as acne, endometriosis, and polycystic ovarian syndrome. In 2008, the hormonal contraceptives market was worth $6.2 billion across the seven major pharmaceutical countries.
Scope
- Analysis of the global hormonal contraceptive prescriptions from 200408, split by geographical region, drug class, indication, and brand.
- Discussion of key commercial opportunities and threats in the US, Japan, and five major European markets.
- In depth profiles of key current hormonal contraceptive brands and pipeline agents with SWOT analyses and country-specific sales forecasts to 2018.
- Detailed analysis of key developer trends, strategies and portfolios including a case study of Bayer-Schering's Yasmin franchise.
Highlights of this title